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Abstract Parkinson’s disease is the second most common age-
related neurodegenerative disease, resulting from loss of
dopaminergic neurons in the substantia nigra. The aggregation
and fibrillation of K-synuclein has been implicated as a causative
factor in the disease, and the process of fibril formation has been
intensively studied in vitro with dilute protein solutions. However,
the intracellular environment of proteins is crowded with other
macromolecules, whose concentration can reach 400 g/l. To
address this discrepancy, the effect of molecular crowding on K-
synuclein fibrillation has being studied. The addition of high
concentrations of different polymers (proteins, polysaccharides
and polyethylene glycols) dramatically accelerated K-synuclein
fibrillation in vitro. The magnitude of the accelerating effect
depended on the nature of the polymer, its length and
concentration. Our results suggest that the major factor
responsible for the accelerated fibrillation under crowded
conditions is the excluded volume. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
Proteins have evolved to function within cells, where the
concentration of macromolecules, including proteins, nucleic
acids, and carbohydrates, and small solutes can be as high as
400 g/l [1]. These intracellular solutes can occupy about half
of the total cellular volume [1^4]. Such media are referred to
as ‘crowded’ rather than ‘concentrated’, as, in general, no
individual macromolecular species is present at high concen-
tration, and a special term, ‘molecular crowding’, has been
introduced to describe the e¡ect of high solute concentrations
on chemical reactions [5,6].
Obviously, the volume occupied by solutes is unavailable to
other molecules because two molecules cannot be in the same
place at the same time. The thermodynamic consequences of
this unavailable volume are called excluded volume e¡ects
[1,7]. Volume exclusion in biological £uids may have large
e¡ects on both stability of biological macromolecules [8^11]
and macromolecular equilibria, including protein^protein in-
teractions [6,12]. Moreover, molecular crowding may lead to
signi¢cant alterations of the rates of chemical reactions, pro-
tein folding and macromolecular association [1,4^7,13]. Fi-
nally, it has been suggested that volume exclusion in physio-
logical media could modulate the rate and extent of amyloid
formation in vivo [6,14]. The validity of this hypothesis has
been con¢rmed recently for the in vitro ¢brillation of human
apolipoprotein C-II [15].
K-Synuclein is a small (14 kDa), highly conserved presyn-
aptic protein that is abundant in various regions of the brain
[16^18]. Structurally, puri¢ed K-synuclein belongs to the fam-
ily of natively unfolded proteins [19^21], which are character-
ized by a unique combination of low overall hydrophobicity
and large net charge [22]. Deposition of aggregated forms of
K-synuclein in neuronal or glial cytoplasm is a pathological
hallmark of several neurodegenerative diseases, including Par-
kinson’s disease, dementia with Lewy bodies, Lewy body var-
iant of Alzheimer’s disease, and multiple system atrophy
[23,24]. In vitro, the protein forms ¢brils with morphologies
and staining characteristics similar to those extracted from
disease-a¡ected brain [25^30]. The kinetics of ¢brillation are
consistent with a nucleation-dependent mechanism [26,31], in
which the critical early stage of the structural transformation
involves a partially folded intermediate [20]. All these experi-
ments have been performed under relatively idealized condi-
tions, low protein and moderate salt concentrations. However,
as mentioned, the inside of the cell is a very crowded environ-
ment, and is poorly modeled by dilute solutions. In the
present study we analyzed the potential role of molecular
crowding in the ¢brillation of human K-synuclein.
2. Materials and methods
2.1. Expression and puri¢cation of recombinant K-synuclein
The expression (in Escherichia coli) and puri¢cation of K-synuclein
were as described previously [20].
2.2. Materials
Thio£avin T (TFT), dextran (molecular mass of 138 000 Da), poly-
ethylene glycols (with molecular masses of 200, 400, 600 and 3350
Da), Ficolls (70 000 and 400 000) were obtained from Sigma, St.
Louis, MO, USA. All other chemicals were of analytical grade from
Fisher Chemicals.
2.3. Fibril formation assay
Assay solutions contained 15 WM TFT and K-synuclein at a con-
centration of 70 WM (1.0 mg/ml) in 20 mM Tris^HCl, 0.1 M NaCl,
pH 7.5, and the desired concentrations of the crowding agent. A
volume of 100 Wl of the mixture was pipetted into a well of a 96-
well plate (white plastic, clear bottom) and a 1/8Q diameter Te£on
sphere (McMaster-Carr, Los Angeles, CA, USA) was added. Each
sample was run in triplicate or quadruplicate. The plate was loaded
into a £uorescence plate reader (Fluoroskan Ascent) and incubated at
37‡C with shaking at 300^600 rpm with a shaking diameter of 1 mm.
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The £uorescence was measured at 30-min intervals with excitation at
450 nm and emission at 485 nm, and curve-¢t as described in [32].
3. Results
3.1. High concentrations of crowding proteins a¡ect
K-synuclein ¢brillation
Molecular crowding e¡ects may be examined experimen-
tally in vitro by using concentrated solutions of a model
‘crowding agent’ such as polyethylene glycol, dextran, Ficoll
and proteins [7,15]. We have studied ¢brillation of human
recombinant K-synuclein in model crowded environments us-
ing changes in TFT £uorescence. TFT is a £uorescent dye that
interacts with amyloid ¢brils leading to an increase in £uores-
cence intensity in the vicinity of 480 nm [33,34]. Fig. 1 shows
that high concentrations of inert proteins such as lysozyme
(50 mg/ml or 3.5 mM) and bovine serum albumin (BSA; 60
mg/ml or 0.9 mM) dramatically accelerated the process of K-
synuclein ¢brillation. Incubation of lysozyme or serum albu-
min alone at high concentrations did not lead to any increase
in TFT signal (data not shown).
Interestingly, under the experimental conditions used, BSA
showed a larger acceleration e¡ect than lysozyme. We consid-
ered the di¡erences in the biophysical characteristics of these
proteins as a possible explanation. Lysozyme is a small glob-
ular protein with molecular mass 14.3 kDa and pI 9.32,
whereas BSA has molecular mass of 66.4 kDa and pI 5.6.
Since both these proteins, with quite di¡erent net charges
(+8 and 317 for lysozyme and BSA, respectively), both accel-
erated K-synuclein ¢brillation, the e¡ect of speci¢c electro-
static interactions between K-synuclein and the crowding pro-
teins can be eliminated. The stronger e¡ect of BSA may be
Fig. 1. E¡ect of high concentrations of lysozyme (50 mg/ml; triangles) and BSA (60 mg/ml; reversed open triangles) on ¢brillation of human
recombinant K-synuclein. A: Limited time range; B: extended time range. The time course of TFT changes for K-synuclein alone (the control)
is shown for comparison (open circles). The symbols represent TFT £uorescence intensities determined experimentally, and the lines are results
of data ¢tting according to [32]. K-Synuclein concentration was 1 mg/ml (70 WM) throughout these experiments. Conditions were 25 mM so-
dium phosphate bu¡er, pH 7.5, 100 mM NaCl, 37‡C.
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due to the di¡erence in their excluded volumes; BSA and
lysozyme have Stokes radii, RS, of 33.9 and 19.0 Aî , respec-
tively [35], which corresponds to a 5.7-fold di¡erence in their
molecular hydrodynamic volumes. Thus, the total excluded
volume of BSA in our experiments is V1.5-fold larger than
that of lysozyme, as the molar concentration of latter is 3.9-
times higher than that of former. Thus, the e¡ective concen-
tration of K-synuclein was V1.5-times higher in the solution
of BSA than in the presence of lysozyme. We attribute the
increased rate of ¢brillation with BSA due to this excluded
volume e¡ect, since we have shown that the rate of ¢brillation
is concentration dependent [36].
3.2. Polyethylene glycols accelerate K-synuclein ¢brillation in
a concentration- and chain length manner
Fig. 2A shows that K-synuclein ¢brillation was dramatically
accelerated in the presence of high concentrations of polyeth-
ylene glycols (150 mg/ml). The data indicate that the polyeth-
ylene glycol length plays a crucial role in the acceleration of
¢bril formation by K-synuclein, with longer polymers inducing
faster K-synuclein ¢brillation. We assume that this is due to
the fact that longer polymers will have larger excluded vol-
umes, giving rise to higher values for the e¡ective K-synuclein
concentration in solution. In these experiments the viscosity
increased linearly with the increase in PEG length from
1.536 þ 0.004 to 4.659 þ 0.008 cP for 150 mg/ml solutions of
ethylene glycol and PEG-3350, respectively. Such an increase,
although relatively small, may a¡ect the rates of macromolec-
ular di¡usion and consequently a¡ect the rates of ¢bril for-
mation. Thus, the increased viscosity in the presence of poly-
ethylene glycols with longer chain length could slow down the
K-synuclein ¢brillation. However, we have established that
Fig. 2. E¡ect of polyethylene glycols on ¢brillation of human recombinant K-synuclein. A: Fibrillation of K-synuclein in the presence of 150
mg/ml of PEG-200 (gray triangles), PEG-400 (open triangles), PEG-600 (gray diamonds) and PEG-3350 (open diamonds). Data for 150 mg/ml
ethylene glycol (molecular mass of 62.1 Da) are shown for comparison (black circles). The control, K-synuclein alone, is shown by the open
circles. B: Fibrillation of K-synuclein in the presence of di¡erent concentrations of PEG 3350: 25 mg/ml (gray circles), 50 mg/ml (gray trian-
gles), 75 mg/ml (open triangles), 100 mg/ml (gray diamonds), 125 mg/ml (open diamonds) and 150 mg/ml (gray squares). Other conditions were
the same as in Fig. 1.
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40% glycerol, which has a similar viscosity to 150 mg/ml PEG-
3350, leads to six-fold slower kinetics of K-synuclein ¢brilla-
tion compared to PEG-3350. Thus, viscosity is not the pri-
mary limitation, and we conclude that excluded volume is the
critical factor in accelerating K-synuclein ¢brillation.
Fig. 2B depicts the e¡ect of increasing the PEG-3350 con-
centration on the rate of K-synuclein ¢brillation. The process
of ¢bril formation was signi¢cantly accelerated by the pres-
ence of 25 mg/ml of PEG-3350, and subsequent increases in
the polyglycol concentration lead to further increases in the
rate of K-synuclein ¢brillation. Interestingly, concentrations of
PEG-3350 above 75 mg/ml showed relatively similar acceler-
ating e¡ects on K-synuclein ¢bril formation, possibly due to
compensating e¡ects of the increased viscosity, which will
work in the direction opposite to that of the excluded volume
(see above) and decrease the acceleration due to the excluded
volume e¡ect. In other words, without the o¡setting viscosity
e¡ect the rates of ¢brillation would continue to increase with
increasing concentrations of PEG above 75 mg/ml.
3.3. Polysaccharides facilitate ¢bril formation of K-synuclein
Fig. 3 illustrates the e¡ect of di¡erent polysaccharides, such
as dextran-138000 (gray diamonds), Ficoll-70000 (gray trian-
gles) or Ficoll-400000 (gray squares), on the rate of K-synu-
clein ¢brillation in vitro. The rate of ¢bril formation increases
signi¢cantly with 150 mg/ml neutral sugar polymers. Several
important observations can be made based on these data.
First of all, high concentrations of polysaccharides show com-
parable e¡ects to those of ethylene glycol (the monomer), and
smaller e¡ects than PEGs (cf. Figs. 2 and 3). Although the
Ficolls are very di¡erent in their molecular masses, they show
relatively similar accelerating e¡ects, with Ficoll-400000 being
a slightly better accelerator than Ficoll-70000. Among the
polysaccharides, dextran-138000 had the smallest accelerating
e¡ect on K-synuclein ¢brillation. These last two observations
may be due to the relatively high viscosities of the polysac-
charide solutions; the viscosities were 4.471 þ 0.008,
11.171 þ 0.012 and 20.276 þ 0.018 cp for Ficolls 70000,
400000 and dextran, respectively.
4. Discussion
Our results demonstrate that molecular crowding causes
substantial acceleration of human K-synuclein ¢brillation in
vitro. Interestingly, the stimulation was observed in the pres-
ence of high concentrations of both charged and neutral pol-
ymers, namely proteins, polysaccharides and polyethylene gly-
cols. The magnitude of the accelerating e¡ect depended on the
nature of the polymer, its length and concentration. In partic-
ular, increasing polymer concentration or polymer size de-
creased the length of the initial lag in ¢brillation, and in-
creased the rate of ¢bril growth. The kinetics of protein
aggregation, involving an initial lag followed by exponential
growth of aggregates, are usually ascribed to nucleated poly-
merization, in which the lag corresponds to the formation of a
critical nucleus. It is assumed that formation of the nucleus is
a rare event involving the simultaneous assembly of several
monomeric intermediate species. Once formed, however, the
nucleus rapidly transforms to ¢brils which grow exponentially
through elongation.
Our data are most consistent with the major e¡ect on the
acceleration of ¢brillation being due to excluded volume ef-
fects, which will favor self-association of K-synuclein due to
the e¡ective increased protein concentration. We have previ-
ously shown that increasing the concentration of K-synuclein
leads to increased rates of ¢brillation [20]. The decreased
water activity in the polymer solutions is also likely to make
a contribution to the acceleration, due to decreasing the sol-
ubility of the protein, and thus also favoring self-association.
In contrast, these accelerating e¡ects are o¡set to a limited
extent by the increased viscosity of the polymer solutions at
high concentration, which will decrease the rate of formation
Fig. 3. E¡ect of high concentrations of polysaccharides on ¢brillation of human recombinant K-synuclein. Symbols correspond to ¢brillation of
K-synuclein alone (open circles), or in the presence of 150 mg/ml of dextran-138000 (gray diamonds), Ficoll-70000 (gray triangles) or Ficoll-
400000 (gray squares). The symbols represent TFT £uorescence intensities determined experimentally, and the lines are results of data ¢tting ac-
cording to [32]. Other conditions were the same as in Fig. 1.
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of the ¢bril nucleus and the rate of ¢bril growth due to the
decreased di¡usion rates. The major e¡ect of the high concen-
trations of polymers was to decrease the length of the lag,
corresponding to formation of the critical nucleus. This e¡ect
is consistent with an excluded volume e¡ect and not the in-
crease in viscosity.
As discussed, a high concentration of macromolecules is a
characteristic feature of the living cell, and most physiological
£uids [1^4]. Our results con¢rm that volume exclusion e¡ects
are general phenomena, and that it is important to take them
into account. The modulating role of excluded volume e¡ects
in the rate and extent of amyloid formation in vivo has been
previously suggested [6,14]. The validity of this hypothesis has
been con¢rmed recently for the in vitro ¢brillation of human
apolipoprotein C-II [15], and now, in this paper, for ¢bril
formation by human K-synuclein.
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